JAZMINE IRIZARRY: Open Payments
NPI 1942807524 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 16 payments from 9 companies in 2025. Trend: 2023 $160 · 2024 $522 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 4 | $91 |
| Astellas Pharma US Inc | 4 | $77 |
| Lilly USA, LLC | 2 | $31 |
| Alkermes, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $24 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
Products named: BRIXADI, Veozah, MOUNJARO, VIVITROL, Kerendia, The Cologuard Plus Collection Kit, PREVNAR 20, BEXSERO.
Industry payments across PA — which companies pay providers there.
